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INTRODUCTION
Recent data regarding the metabolism of androgens suggest that testosterone is transformed into different active metabolites for use by the target organs (1, 2) . These metabolites may have different effects, and currently the summation of the different metabolite functions is used to define the action of the parent compound. Thus the anabolic, masculinizing, and erythropoietic activity of androgens could very well be a summation of different activities of various metabolites. The need for a hematoReceived for publication 26 December 1972 and in revised form 23 April 1973. poietic agent void of virilizing and salt-retaining properties led us to search for an active metabolite that is primarily erythropoietic.
The reduction of the A4 unisaturationi of the A ring in testosterone results in the fornmation of 5a and 50 derivatives (1. 2) . The 5a derivatives are androgenic but the 5V3 steroids were devoid of this property (3) in the rodent assay system. A group of naturally occurring metabolites with 5p-H configuration, in which the junction between the first two rings (A: B cis) of the steroid nucleus is highly angulated (Fig. 1) , has been found to have a potent ability to induce heme synthesis (4) independent of erythropoietin (5, 6) . The erythropoietic action of androgens in animals and man has been attributed to increase erythropoietin production (7, 8) , with a possible direct bone marrow cell effect (9, 10) . The stimulation of erythropoiesis by testosterone has been successfullv blocked by antierythropoietin (8) . The 5k-H steroids stiniiulate lheme synthesis by increasinig 6-aminiolevulinic alcid synthetase in the avian liver (11) and(I in blood islands of explanted de-embryoinated clhick blastoderm (12) , and recently they have been reported to enhance heme and globin synthesis in human bone marrow culture (13) (14) (15) (16) . The 59-H steroids were also capable of increasing 'Fe incorporation in red cells of normal and polycythemic mice and rats (5, 17) . However, some investigators failed to demonstrate this effect in mildly plethoric (18) and polycythemic mice (19) . The present in vivo study was diet,' supplemented with fruits and water, ad libitum. 3 wk before the studies were begun all monkeys received 5 mg of iron-dextran (Imferon) 2 i.m. to ensure adequate iron stores. The cage areas were maintained on a 12-h on, 12-h off light cycle and at an average temperature of 25'C. Sodium pentothal (2 mg i.p.) was used to anesthetize the monkey. The femoral vein was always used to obtain blood or for intravenous administration. Complete blood counts were done using standard techniques. All radioactive counts were done in an automatic well-type scintillation counter.3
The treated group (5,8-H group) was given 5j8-pregnane-3#-hydroxy-20-one' (Fig. 2) , dissolved in 10% N,N-dimethylacetamide and propylene glycol (1,2-propanediol) ' at 25 mg/kg body weight i.m. (0.2 ml); the control group received the diluent (vehicle) only. Dosage schedules were as follows: for the ferrokinetic studies, steriod or vehicle was injected 48-72 h before measurements were done. For the red cell survival and blood volume studies, the monkeys were given five weekly injections of the steroid or the vehicle.
Ferrokinetics. Plasma iron clearance, plasma iron turnover, 'Fe red cell incorporation, and marrow maturation time were determined using methods previously described (20, 21) with the following modifications for microtechnique. The femoral vein was cannulated with an intramedic (PE-90/S12') polyethylene catheter6 for repeated removal and readministration of blood. Initially, 6 ml of blood were removed for plasma iron determination. From this sample, 1.5 ml of plasma were incubated with 0.25 uCi of 'Fe citrate at 37'C for 20 min, and 1 ml of the labeled plasma was injected i.v. Thereafter, 50 ,ul of plasma were separated from 1 ml of blood drawn at 5, 15, 30, 60, 90, 120, and 180 min. The radioactive counts were obtained from all samples and plotted on semilogarithm paper to calculate the plasma iron clearance. After reconstitution, all red cells were reinfused with saline to maintain the monkey's hematocrit. All studies were initiated at 2:00 p.m. each day to minimize the diurnal variation in plasma iron. Plasma volume was calculated by '9Fe dilution at 0 time.
"Fe red cell uptake anid marrow maturation time. 'Fe red cell uptake was determined and completed in 10 monkeys. The same procedure was done as for the clearance studies and continued by counting 100 gl of blood radioactivity at days 1-5, 7, 9, 11, and 15. Results were plotted as percent of 'Fe uptake.
Blood voluime determninations. A modification of the method of Read (22) to measure blood volume was used for microtechnique before the first administration of the vehicle or the steroid, and a week after the last injection. A sample of 2 ml of blood was drawn and immediately placed in a sterile vial with 0.25 ml acid citrate dextrose' (special formula). Sodium-51chromate' (5 5a-H and 5fi-H Levere, Gordon, ml of blood was removed, diluted to 1.0 ml, and from this mixture 0.1 ml was re-injected. The hematocrit was measured after the dilution. Radioactive counts were determined from the rest of the sample by pipetting 100 jul whole blood and 50 ,ul of plasma standard into a well-type scintillation counter. The same amount of whole blood and plasma was counted from the 30-min sample, and the hematocrit was measured. Calculations of the red cell mass were done with the standard formula correcting all volumes of 1 ml as follows:
[(CWB Std) (10) Red cell survival. Red cell half-life was measured after the second blood volume determination using the "Cr-tagged red cells given for the volume measurements. 1 ml of blood was drawn at 24 h and weekly thereafter for 21 days, and 100-,ul aliquots were counted for radioactivity. Counts were plotted on semilogarithm paper, and the erythrocyte halflife was calculated. The 30-min vhole blood was used as the 100% baseline value.
RESULTS
Ferrokinetics. The plasma iron levels in the control and the 5#-H groups are noted in plasma iron clearance and a twofold increase (P < 0.02) in plasma iron turnover after treatment with the netabolite.
59Fe red cell uptake was 80% to 100%,t^a t 7 days for the control group and the 5p-H group, except for two monkeys with 80% at 3 days. However, the mean marrow maturation time was the same for both groups as listed in Table I . Blood volumes. The red cell mass (5tCr) of a nontreated 655-g monkey averaged 13.3±0.7 ml (pretreatment values for both treated and control monkeys). After treatment for 5 wk, the red cell mass of the control group did not change, while the 5,3-H group increased their red cell mass (Table II) . Plasma volume in the 5p-H group increased 10.6 ml (P <0.001). (23) .
Blood counts. The white cell counts in the 5p-H and control groups after 5 wk of drug administration were 10,400 mm' and 6,700 mm'/,ul, respectively, (P <0.01) both with normal differential. The 5#-H group had a slight elevation (P < 0.2) of the mean platelet count to 350,000 mm3/tl (control = 295,000 mm3/l). The hematocrits of both groups did not change compared to their pretreatment levels. The 5p-H group maintained its hematocrit by elevating both the red cell mass and the plasma volume.
DISCUSSION
A number of steroid metabolites with the 5,8-H configuration has been known to play a role in regulation of erythropoiesis. The increase in heme-prophyrin biosynthesis in the erythroid models was related to the induction of 8-aminolevulinic acid synthetase (12) , the rate-limiting enzyme in the production of heme (24) . Values expressed as mean±SEM.
crease 5-aminolevulinic acid synthetase in the rabbit bone marrow culture (25) , suggesting a similarity in the site of action between the 5k-H steroids and erythropoietin. However, plasma from 5P-H steroid-treated rats (5) and mice (6) failed to demonstrate any erythropoietic activity. The erythropoietic activity of the steroid could not be abolished by antierythropoietin (5). These observations may imply that the 5#-H steroid metabolite has a unique role in the regulation of red cell production that is not related to erythropoietin. Byron (26, 27) and other workers (28) demonstrated another role of these steroids. The 5p-H steroid triggers the hemopoietic cells into cycle, presumably "pushing" stem cells into an erythropoietin-sensitive state (29) . However, this "cycling" effect on hemopoietic stem cells was also described with dibutyryl cyclic AMP (26) and testosterone (27) and thus is not unique to the 5p-H steroid. Necheles observed a synergistic effect with erythropoietin in stimulating wFe uptake in human marrow cultures if the 5#-H steroid was added 24 h before erythropoietin. He thus proposed that induction of 5-aminolevulinic acid synthetase plays a role in the regulation of the stem cell differentiation into the red cell series (30) .
In the current study we found shortening of plasma iron clearance and an increased plasma iron turnover 48-72 h after the 5k-H steroid was administered. One possible interpretation is that induction of 8-aminolevulinic acid synthetase and thus differentiation of the stem cell (30) , induced by the 5p-H steroid, took place within 24 h. These triggered cells became receptive to erythropoietin, thereby differentiating into erythroid cells. The erythropoietic response, in turn, is reflected 48 h later by a rapid iron clearance and an increased iron turnover. This time sequence is compatible with the previous observations about erythropoietin cell responsiveness (30) . The acceleration of the plasma iron clearance induced by the steroid may reflect an increased marrow response with greater production of hemoglobin (31) . Plasma iron clearance is affected by several other conditions, such as ineffective erythropoiesis or hemolysis (31) . The red cell survival studies suggest a normal erythrocyte life-span in the steroid-treated monkeys, thus eliminating the possibility of lhemolysis, and the presence of short-lived cells of stress erythropoiesis (32) . The increase in red cell mass indicates that this is in fact an effective erythropoiesis.
The increase in platelets and leukocyte count suggests not only an erythroid stimulation but also possibly a direct stem cell effect. These increments, which occurred in the presence of an expanded blood volume, are more significant in view of the possible dilution factor. This stem cell differentiation from other cell lines may be more prominent with the 5f-H steroids as compared to androgens, possibly because of the absence of endogenous erythropoietin stimulation with the steroid metabolites. A possible shift between circulating and marginal granulocyte pool may also explain a high leukocyte count. This so-called pseudoneutrophilia can occur acutely after administration of epinephrine or etiocholanolone (33) . However, in this study neutrophilia was observed after 5 wk of steroid administration.
The increase in white blood count, platelets, and iron turnover could be partially explained by rapid release of cells from the bone marrow by the 5p-H steroid in addition to a stem cell stimulation. Recently, the 5fi-H steroid has been reported to cause rapid release of reticulocytes from rat marrow (34) . Although our 50% marrow maturation time was not significantly altered, two out of five monkeys in the 5p-H steroid group in our study incorporated more than 80% of the 'Fe in 3 days, as compared to a control group time of 7 days. The rate of release of other cell lines in this study was not measured.
The data thus presented, in conjunction with previous studies of the erythropoietic activity of the 5#-H steroids, demonstrate that these metabolites can not only stimulate activity via induction of 8-aminolevulinic acid synthetase in vitro in erythroid tissues of birds, rodents, and human bone marrow cultures, but also stimulate in vivo erythropoiesis in primates. The possible use of these naturally occurring metabolites of testosterone and progesterone should be evaluated in therapeutic programs for certain refractory anemias in man. The possible stimulatory effect on granulopoiesis and megakaryopoiesis also suggests further investigation for possible use in disease states associated with pancytopenia and marrow suppression. The 5t3-H steroids may be particularly useful as therapeutic agents in wonmen and clhildreni, because they have been found to be devoid of the undesirable androgenic side effects in animal assay studies.
